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A CH2Cl2 complex of a [Rh(pincer)]
+ cation†
Gemma M. Adams, F. Mark Chadwick, Sebastian D. Pike and Andrew S. Weller*
The CH2Cl2 complex [Rh(
tBuPONOP)(κ1-ClCH2Cl)][BArF4] is reported,
that also acts as a useful synthon for other complexes such as N2,
CO and H2 adducts; while the analogous PNP complex undergoes
C–Cl activation.
Coordinatively and electronically unsaturated transition-metal
pincer complexes, [M(pincer)], are key intermediates in alkane
dehydrogenation processes,1 as well as other catalytic trans-
formations.2 They have also played a major role in the elucida-
tion of fundamental bond transformations, such as C–H,
C–C and C–X breaking and making.3 Recently, Brookhart
and co-workers reported the synthesis of transition-metal
methane and ethane sigma complexes, by a low temperature
(ca. −110 °C to −150 °C) protonation of the correspond-
ing Rh(tBuPONOP)R precursors using [H(OEt2)2][BAr
F
4] in
CDF2Cl–CH2Cl2 solvent to give [Rh(
tBuPONOP)(H-R)][BArF4]
[tBuPONOP = 2,6-(tBu2PO)2C5H3N; R = Me, Et; Ar
F = 3,5-(CF3)2C6H3],
Scheme 1.4 Such complexes are key, but transient, inter-
mediates in C–H bond activation processes. On warming above
−87 °C (R = Me) or −130 °C (R = Et) they lose alkane and gene-
rate complexes tentatively characterised in situ on the basis of
31P NMR spectroscopy as [Rh(tBuPONOP)(solv)][BArF4] (solv =
CDF2Cl or CD2Cl2). These solvent adducts remain to be defini-
tively characterised. They are particularly interesting given
their role in alkane coordination chemistry, and more generally
as latent-low coordinate intermediates in catalytic processes.
We now report the full characterisation of the CH2Cl2
adduct accessed via a diﬀerent, halide abstraction, route
including a single crystal X-ray diﬀraction study and its
onward reactivity. We also demonstrate that changing the
pincer ligand to the more electron donating tBuPNP [2,6-
(tBu2PCH2)2C5H3N] results in C–Cl bond activation of the
solvent molecule.
Addition of Na[BArF4] to a CH2Cl2 solution of Rh(
tBuPO-
NOP)Cl, 1,4a results in the formation of orange [Rh(tBuPONOP)-
(κ1-ClCH2Cl)][BArF4], 2 (Scheme 2). Filtration and removal of
the solvent aﬀords 2 in good isolated yield as a powder.
Complex 2 can be recrystallised from CH2Cl2–pentane under
an Ar atmosphere to give crystals suitable for an X-ray diﬀrac-
tion study. Under these conditions, orange 2 crystallises
alongside the dinitrogen adduct, [Rh(tBuPONOP)(κ1-N2)][BArF4],
3, in an approximate 1 : 1 ratio (as measured by 31P NMR
spectroscopy, vide infra). Single crystals of 2 suitable for an
X-ray diﬀraction study were obtained by mechanical separation
from orange/brown 3.‡ Presumably the exogenous N2 comes
from trace (1–2 ppm) levels of N2 present in the argon, as has
been noted previously,5 and is driven by relative solubilities of
Scheme 1 Formation of a sigma alkane complex and decomposition to
give tentatively characterised solvent complexes (Brookhart and co-
workers). [BArF4]
− anions are not shown.4
Scheme 2 Synthesis of complex 2. [BArF4]
− anion is not shown.
†Electronic supplementary information (ESI) available: Full experimental,
characterisation and X-ray crystallography details. CCDC 1044741, 1044743,
1044744 and 1044745. For ESI and crystallographic data in CIF or other elec-
tronic format see DOI: 10.1039/c5dt00481k
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2 and 3; as in neat CD2Cl2 under the same Ar atmosphere 2
does not go onto to form 3 to the detection limit of 31P{1H}
NMR spectroscopy. The solid-state structure (Fig. 1A) shows a
pseudo square planar cationic [Rh(tBuPONOP)]+ centre co-
ordinated in the fourth position by a CH2Cl2 molecule. The
Rh–Cl1 distance [2.350(2) Å] is significantly shorter than
reported for related [RhCp*(PMe3)(Ph)(κ1-ClCH2Cl)][BArF4],6
2.512(2) Å, and [RhCp*(PMe3)(Me)(κ1-ClCH2Cl)][BArF4],
2.488(1) Å Cp* = η5−C5Me5).7 Complex 2 adds to the relatively
small number of CH2Cl2 complexes that have been crystallo-
graphically characterised, and in particular CH2Cl2 adducts of
pincer, or closely related, complexes.8
Although the short Rh–Cl distance might suggest a stronger
interaction in 2, in solution (vide infra) rapid exchange
between solvent and bound CH2Cl2 occurs. The two C–Cl dis-
tances in the bound solvent molecule are similar, 1.710(8)
[C22–Cl1] and 1.758(7) [C22–Cl2] Å, although the distal C–Cl
bond is the slightly longer of the two. This is in contrast to
other reported CH2Cl2 complexes in which the bound C–Cl
bond is longer.8,9 We suggest that the slight lengthening of
C22–Cl2 may be due to a number of weak C–H⋯Cl hydrogen
bonds between proximal tBu groups and Cl2.10
Complex 2 is stable in the solid-state under an Ar atmos-
phere, and in solution (CD2Cl2) for at least 1 week. In the
31P{1H} NMR spectrum (CD2Cl2) a single resonance is observed at
δ 204.5 [J (RhP) 136 Hz]. These data are identical to those pre-
viously reported by Brookhart and co-workers for the complex
tentatively characterised as [Rh(tBuPONOP)(CH2Cl2)][BAr
F
4], i.e.
2. The tBu groups are observed as a single environment in the
1H NMR spectrum. The bound CH2Cl2 ligand is not observed,
even at −80 °C in the 13C{1H} NMR spectrum, presumably as it
is undergoing fast exchange with the solvent.11 The electro-
spray ionisation mass spectrum of 2 using N2 as a desorption
gas showed only 3 as the molecular ion.
Complex 2 is a useful synthon for the preparation of other
pincer complexes (Scheme 3). Addition of H2 to a CD2Cl2
solution of 2 forms the previously reported dihydrogen com-
plex [Rh(tBuPONOP)(η2-H2)][BArF4]12 [δ(1H) −8.27, lit. −8.26].
Addition of N2 forms the new complex [Rh(
tBuPONOP)(κ1-N2)]-
[BArF4], 3, for which a solid-state structure is shown in Fig. 1B.
This demonstrates an end-on bound, monomeric, N2 adduct
[N–N, 1.063(5); Rh–N2, 1.967(3) Å]. The 31P{1H} NMR spectrum
displays a single environment at δ 211.0 [ J (RhP) 132 Hz], while
in the IR spectrum the N–N stretch is observed at 2201.9 cm−1.
The N–N bond length is very similar (albeit a little shorter)
than that in free N2 [1.09 Å], suggesting only a small degree of
activation. Complex 3 can also be compared with previously
reported [Rh(tBuPNP)(κ1-N2)][OTf] which shows a slightly
longer N–N bond, a shorter Rh–N bond and a more red-shifted
N–N stretch: 1.116(4), 1.898(3) Å, and 2153 cm−1 respectively;
suggesting greater N2 activation for this more electron rich
pincer ligand.13 This greater metal-based basicity in the
tBuPNP complexes is reflected in the CO stretching frequencies
of the corresponding CO-adducts: [Rh(tBuPONOP)(CO)][BArF4],
4 [2020 cm−1] and [Rh(tBuPNP)(CO)][BArF4] [1982 cm
−1].14
Complex 4 was prepared by adding CO to a CH2Cl2 solution of
2, further demonstrating the utility of complex 2 in synthesis.
The diﬀerence in electron-donating power of the tBuPONOP
versus tBuPNP ligands can also been shown by the attempted
synthesis of the CH2Cl2 adduct of the {Rh(
tBuPNP)}+ fragment,
analogous to complex 2. Rather than simple coordination, this
resulted in a number of products as measured by 31P{1H} NMR
spectroscopy. Analysis of single crystals suitable for an X-ray
Fig. 1 Solid-state structures of: (A) Complex 2; (B) Complex 3; (C) Complex 5. Displacement ellipsoids are shown at the 50% probability level, hydro-
gen atoms and the [BArF4]
− anions are not shown. Selected bond lengths (Å) and angles (°): (2) Rh1–Cl1, 2.350(2); Rh1–N1, 2.011(4); Rh1–P1, 2.272(1);
Rh1–P2, 2.285(1); Cl1–C22, 1.710(8); Cl2–C22, 1.758(7); Cl1–C22–Cl2, 114.3(4); N1–Rh1–Cl1, 169.65(11). (3) Rh1–N1, 2.018(3); Rh1–N2, 1.967(3);
Rh1–P1, 2.2745(8); Rh1–P2, 2.2724(8); N2–N3, 1.063(5); Rh1–N2–N3, 179.3(4); N1–Rh1–N2, 179.37(13). (5) Rh1–Cl1, 2.311(2); Rh1–N1, 2.066(6);
Rh1–P1, 2.335(2); Rh1–P2, 2.339(2); Rh1–C8, 2.196(15); C8–Cl2, 1.79(2); Rh1–C8–Cl2, 112.5(9). Complex 5 co-crystallises with [Rh(tBuPNP)(H)Cl]-
[BArF4], 6, at the same lattice position in a 50 : 50 ratio.‡



























































































diﬀraction study, obtained from recrystallisation of the reac-
tion mixture, demonstrated co-crystallisation of two complexes
[Rh(tBuPNP)(CH2Cl)Cl][BAr
F
4], 5, and [Rh(
tBuPNP)-(H)Cl]
[BArF4], 6, in an approximate 50 : 50 ratio (Scheme 4); for
which the solid-state structure of 5 is shown in Fig. 1C.
Because of this co-crystallisation the metrical data associated
with 5 should be treated with caution. The 1H NMR spectrum
of these crystals showed a broad hydride signal at δ −15.48
(relative integral relative to [BArF4] of ∼0.5 H) which is assigned
to 6. Given the number of products formed we are reluctant to
speculate on mechanism of formation of 6, but protonation of
5 by trace acid arising from other decomposition pathways
could form 6. Addition of H2 to this mixture of 5 and 6 in
CD2Cl2 aﬀorded mixture of products, from which [Rh(
tBuPNP)-
(η2-H2)][BArF4] could be identified as the major species present.16
Conclusions
The CH2Cl2 complex [Rh(
tBuPONOP)(κ1-ClCH2Cl)][BArF4] has
been isolated, confirming its formation in the decomposition
of the corresponding alkane adduct at low temperature, itself
formed from protonation of an alkyl precursor.4 Synthesis has
been achieved by an alternative halide-abstraction route in
CH2Cl2 solvent, starting from a readily available chloride precur-
sor. This complex, with its weakly bound CH2Cl2 ligand, also
acts as a useful synthon for other complexes such as N2, CO and
H2 adducts. The corresponding PNP ligand complex undergoes
C–Cl activation to form a mixture of products, highlighting the
diﬀerence in electron donating properties of these two ligands.
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